Are Endometrial Stem Cells Novel Tools against Ischemic Heart Failure in Women? A Hypothesis

AUTHORS

J Ai 1 , D Mehrabani 2 , *

1 Department of Tissue Engineering, Research Center for Science and Technology in Medicine, Tehran University of Medical Sciences, Iran

2 Stem Cell and Transgenic Technology Research Center, Gastroenerohepathology Research Center, Department of Pathology, Nemazee Hospital, Shiraz University of Medical Sciences, [email protected], Fars, Iran

How to Cite: Ai J, Mehrabani D. Are Endometrial Stem Cells Novel Tools against Ischemic Heart Failure in Women? A Hypothesis, Iran Red Crescent Med J. Online ahead of Print ; 12(1):73-75.

ARTICLE INFORMATION

Iranian Red Crescent Medical Journal: 12 (1); 73-75
Article Type: Dissertation
Received: June 10, 2009
Accepted: October 9, 2009

Crossmark

CHEKING

READ FULL TEXT
Abstract

Recently stem cell therapy has suggested novel therapeutic strategies for management of heart failure and myocardial infarction. Our aim was to show that endometrial stromal cells produce a higher overall clonogenicity with a high angiogenesis potential. In addition, they may be converted into osteoblasts, odentoblasts, chindroblasts, neuroblasts and myoblasts and can be used for cell therapy as autologous and heterologous transplantations in future studies.

 

Keywords

Endometrium Stem cell Ischemic heart disease

© 0, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.

Full Text

Full text is available in PDF

COMMENTS

LEAVE A COMMENT HERE: